πŸ‡ΊπŸ‡Έ FDA
Preview mode β€” showing bulk-ingested data not yet promoted to production. Hide preview

Intelligence Β· INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
3,385
Companies
1,062
Pipeline programs
18,156

Quick answer

NovaPharmaNews tracks 3,385 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

122 results for β€œVIR” Clear

  1. abacavir

    KIVEXA

    ORAL approved

    J05AR13

  2. abacavir sulfate

    ABACAVIR SULFATE Teva Pharma GmbH

    ORAL approved

  3. abacavir, dolutegravir, lamivudine

    ABACAVIR || DOLUTEGRAVIR || LAMIVUDINE

    approved

  4. acyclovir

    ZOVIRAX Amneal Pharma Europe Ltd

    OPHTHALMIC approved

  5. acyclovir sodium

    ACYCLOVIR SODIUM Teva Pharma GmbH

    INJECTION approved

  6. adefovir dipivoxil

    HEPSERA

    ORAL approved

    J05AF08

  7. adenovirus-mediated herpes simplex virus-thymidine kinase gene

    CEREPRO Ark Therapeutics

  8. alkavervir

    VERILOID

    ORAL approved

  9. allogeneic t cells genetically modified with a retroviral vector encoding for a truncated form of the human low affinity nerve growth factor receptor (Ξ΄lngfr) and the herpes simplex i virus thymidine kinase (hsv-tk mut2)

    ZALMOXIS

    L01

  10. amprenavir

    AGENERASE

    ORAL approved

    J05AE05

  11. atazanavir

    ATAZANAVIR VIATRIS (PREVIOUSLY ATAZANAVIR MYLAN)

    J05AE08

  12. atazanavir sulfate

    REYATAZ Amneal Pharma Europe Ltd

    ORAL approved

    J05AE08

  13. autologous cd34+ enriched cell fraction that contains cd34+ cells transduced with retroviral vector that encodes for the human ada cdna sequence

    STRIMVELIS

    L03

  14. baloxavir marboxil

    XOFLUZA

    ORAL approved

  15. bictegravir

    BIKTARVY

    J05AR20

  16. bictegravir sodium

    BIKTARVY

    ORAL approved

  17. bictegravir, emtricitabine and tenofovir alafenamide

    BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

    approved

  18. boceprevir

    VICTRELIS

    ORAL approved

    J05AE

  19. brincidofovir

    TEMBEXA

    ORAL approved

  20. bulevirtide

    HEPCLUDEX

    J05A

  21. cabotegravir

    APRETUDE

    INTRAMUSCULAR approved

    J05AX

  22. cabotegravir sodium

    VOCABRIA

    ORAL approved

  23. cidofovir

    VISTIDE

    INTRAVENOUS approved

    J05AB12

  24. daclatasvir

    DAKLINZA

    J05AP07

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 3,385 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources